Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase

Thirty patients with Parkinson's disease were treated for four weeks with levodopa combined with an inhibitor of extracerebral dopa decarboxylase, L-alpha-methyldopahydrazine (MK 486). The therapeutic results were compared with the effects of treatment of a group of 40 patients with levodopa alone. Patients treated with the combined therapy improved more rapidly, had less nausea and vomiting, and required a much smaller dose of levodopa than patients treated with levodopa by itself.

[1]  S. Udenfriend,et al.  Evaluation of the biochemical effects produced in vivo by inhibitors of the three enzymes involved in norepinephrine biosynthesis. , 1966, Molecular pharmacology.

[2]  Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). , 1971, Transactions of the American Neurological Association.

[3]  W. Burkard,et al.  Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase , 1967, Nature.

[4]  W. Birkmayer.  [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)]. , 1969, Wiener klinische Wochenschrift.

[5]  G C Cotzias,et al.  Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.

[6]  A. Barbeau,et al.  Treatment of Parkinson's disease with levodopa and Ro 4‐4602 , 1971, Clinical pharmacology and therapeutics.

[7]  L. Watson,et al.  Inhibition of dopa decarboxylase by the hydrazino analog of α-methyldopa , 1962 .

[8]  J. Gaillard,et al.  [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)]. , 1969, La Presse medicale.

[9]  T. Chase,et al.  Effect of L‐dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes , 1970, Clinical pharmacology and therapeutics.

[10]  T. Chase,et al.  Inhibition of drug metabolism by levodopa in combination with a dopa-decarboxylase inhibitor. , 1971, Lancet.

[11]  J. Reid,et al.  Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa , 1971, British medical journal.

[12]  C. Marin,et al.  [Treatment of parkinsonism with L-dopa]. , 1970, Acta neurologica latinoamericana.

[13]  C. Marsden,et al.  Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. , 1971 .